BLUEPRINT MEDICINES CORP (BPMC) Top Institutional Shareholders
BLUEPRINT MEDICINES CORP (BPMC) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $38,583 in BPMC holdings during the latest filing period.
Kelleher Financial Advisors is currently the largest disclosed institutional shareholder of BPMC tracked by InsiderSet, reporting ownership valued at approximately $38,454 in its March 31, 2026 SEC Form 13F filing.
The top 10 institutional shareholders tracked on this page collectively account for approximately 100% of the total disclosed BPMC value among the investors covered in this analysis. Major shareholders include Kelleher Financial Advisors, Huntington National Bank, and several other long-term asset managers with concentrated positions in BLUEPRINT MEDICINES CORP (BPMC).
This page ranks the largest institutional BPMC shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
2
Total Reported Value
$38,583
Largest Holder
Kelleher Financial Advisors
Largest Position
$38,454
Insider Transactions (90d)
0
Latest Filing Quarter
Q1 2026
New Institutional Positions
9
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Kelleher Financial Advisors | 0.01% | 300 | $38,454 | — | — | — | |
| Huntington National Bank | 0.00% | 1 | $129 | — | — | — |
Frequently asked questions about BPMC
Who owns the most BPMC stock?
The largest holders of BPMC are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for BLUEPRINT MEDICINES CORP (BPMC).
Is BPMC widely held by superinvestors?
Many widely followed stocks like BPMC appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly BPMC is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.